Arcutis Biotherapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Arcutis Biotherapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $170K, a 2.86% decline year-over-year.
  • Arcutis Biotherapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $766K, a 18.4% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2023 was $771K, a 24% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2022 was $622K, a 37% increase from 2021.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2021 was $454K, a 272% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $771K +$149K +24% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $622K +$168K +37% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $454K +$332K +272% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $122K +$54K +79.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $68K +$68K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-22
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.